Poster: Other Drug/Disease Modelling

Development of PK/PD Models to describe Pharmacokinetics and Biomarker Responses for Dovitinib (TKI258)

Thursday 16 October, 2025

Objectives: Dovitinib is a potent oral inhibitor of Receptor Tyrosine Kinases (FGFR, VEGFR, PDGFR). It is expected to be effective…

Read more

Population Pharmacokinetic/Pharmacodynamic Modeling of Two Novel Neutral Endopeptidase Inhibitors in Healthy Subjects

Thursday 16 October, 2025

Objectives: UK-447,841 and UK-505,749 are two selective NEP inhibitors that are being investigated for the ‘as required' treatment of the…

Read more

Target-mediated clearance of ofatumumab: a tale of different disease states

Thursday 16 October, 2025

Objectives: Ofatumumab is a CD20-targeted monoclonal antibody indicated for the treatment of patients with refractory chronic lymphocytic leukemia (CLL) and…

Read more

Population pharmacokinetic analysis of robenacoxib in dogs with chronic osteoarthritis

Thursday 16 October, 2025

Objectives: A previous population analysis showed the preferential distribution of the coxib NSAID robenacoxib to inflamed joints in dogs [1]….

Read more

A joint PK/PD-PD model of levodopa in patients with Parkinson’s disease: Motor effect and Movement disorder

Thursday 16 October, 2025

Objectives: After several years of treatment with levodopa, patients with Parkinson’s disease often present movement disorders such as dyskinesia. This…

Read more

Mathematical Model of Homeostasis of Endogenous Hormones Following Hormone Replacement Therapy

Thursday 16 October, 2025

Objectives: Hormone replacement therapy (HRT) is widely used to antagonize low levels of endogenous hormones as e.g. in menopause, hypogonadism,…

Read more

Mechanism of Action of Jellyfish (Carukia barnesi) Envenomation and its Cardiovascular Effects Resulting in Irukandji Syndrome

Thursday 16 October, 2025

Objectives: Jellyfish stings in northern Australia cause significant morbidity and mortality [1]. One of the most popular jellyfishes, Carukia barnesi…

Read more

Physiologically-based PK/PD modeling for a dynamic cardiovascular system: structure and applications

Thursday 16 October, 2025

Objectives: A physiologically-based (PB) cardiovascular (CV) model including a representation of heart (left, right atrium and ventricle), pulmonary, organ and…

Read more

Predicting the antihypertensive effect of Candesartan-Nifedipine combinations based on public benchmarking data.

Thursday 16 October, 2025

Objectives: Calcium channel blocker (CCB) and Angiotensin II receptor blocker (ARB) have demonstrated their efficacy in reducing blood pressure in…

Read more

Modelling of Anti-Drug Antibodies Directed Against a Monoclonal Antibody

Thursday 16 October, 2025

Objectives: Monoclonal antibodies (mAbs) are an important class of biopharmaceuticals. Due to their nature as foreign proteins, they can induce…

Read more